AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

RNA-based Ovarian Cancer Diagnostic

Technology Benefits

Advantages of this approach include the ability to: detect ovarian cancer in the asymptomatic phase of the disease;use tissue samples that are routinely collected in a gynecologic exam; anddetect at high sensitivity (a few tumor cells).

Technology Application

Early detection of ovarian cancer

Detailed Technology Description

UC Inventors have discovered a number of mRNA transcripts that are selectively expressed in ovarian tumors and may be used to detect the presence of an ovarian tumor in a Pap smear and/or endometrial biopsy.

Application No.

20170342504

Others

State Of Development

A number of ovarian tumor-specific transcripts have been identified and relevant primers developed. Work is continuing to identify additional tumor-specific transcripts and to optimize primers for detection in the relevant tissues.

Intellectual Property Info

Worldwide rights available; Pending patents available under confidentiality.

Related Materials

Cramer et al., Ovarian cancer biomarker performance in prostate, lung, colorectral, and ovarian cancer screening trial specimens, 2011; Cancer Prev Res (Phila), 4(3):365-74.
Zhu et. al., A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer, 2011, Cancer Prev Res (Phila), 4(3):375-83

Tech ID/UC Case

24303/2014-349-0

Related Cases

2014-349-0

Country/Region

USA

For more information, please click Here